| |
Mitral repair
|
Mitral replacement
|
P value
|
|---|
|
Total number of patients
|
112
|
106
| |
|
Age>65 years
|
75 (66.9%)
|
77 (72.6%)
|
NS
|
|
Age range (years)
|
70.6 ± 8.6
|
71.8 ± 10.8
|
NS
|
|
Female
|
40 (35.7%)
|
47 (44.3%)
|
NS
|
|
Hypertension
|
81(72.3%)
|
79(74.5%)
|
NS
|
|
Diabetes mellitus
|
33(29.5%)
|
34(32.1%)
|
NS
|
|
Hyperlipidemia
|
80(71.4%)
|
61(57.5%)
|
0.032
|
|
Smoker
|
76(67.9%)
|
81(76.4%)
|
NS
|
|
COPD
|
21(18.8%)
|
24(22.6%)
|
NS
|
|
Pulmonary hypertension
|
38(33.9%)
|
31(29.2%)
|
NS
|
|
Chronic renal insufficiency
|
8(7.1%)
|
6(5.7%)
|
NS
|
|
Peripheral vascular
|
4(3.6%)
|
3(2.8%)
|
NS
|
|
Cerebrovascular accident
|
3(2.7%)
|
2(1.9%)
|
NS
|
|
Atrial fibrillation
|
31(27.7%)
|
28(26.4%)
|
NS
|
|
Previous MI(< 30 days)
|
12(10.7%)
|
10(9.4%)
|
NS
|
|
Previous PCI
|
70(62.5%)
|
45(42.5%)
|
0.003
|
|
NYHA III-IV
|
59(52.7%)
|
52(49.1%)
|
NS
|
|
LVEF < 30%
|
22 (19.6%)
|
24 (22.6%)
|
NS
|
|
Echocardiographic data
| | | |
|
LVEF (%)
|
34.6 ± 5.5
|
35.1 ± 4.3
|
NS
|
|
LVEDD (mm)
|
66.29 ± 6.36
|
65.29 ± 6.36
|
NS
|
|
LVESD (mm)
|
50.21 ± 11.08
|
51.21 ± 11.08
|
NS
|
|
LAD(mm)
|
58.04 ± 17.26
|
57.86 ± 17.15
|
NS
|
|
SPAP(mmHg)
|
47.24 ± 14.31
|
48.01 ± 14.59
|
NS
|
|
Left main disease >50%
|
36(32.1%)
|
39(36.8%)
|
NS
|
|
3-vessel disease
|
91(81.3%)
|
88(83.0%)
|
NS
|
|
Carpentier classification[6], n (%)
| | | |
|
Ia
|
40(35.7%)
|
35(33.1%)
|
NS
|
|
IIIb
|
72(64.3%)
|
71(66.9%)
|
NS
|
|
Severe MR(+4), % (n)
|
69(61.6%)
|
72(67.9%)
|
NS
|
- COPD = chronic obstructive pulmonary disease; MI = myocardial infarction; mod = moderate; PCI = percutaneous intervention; NYHA = New York Heart Association; LVEF = left ventricular ejection fraction; LVEDD = left ventricular end-diastolic diameter; LVESD = left ventricular end-systolic diameter; LAD = left atrial diameter; SPAP = systolic pulmonary artery pressure; Left main disease = left main coronary stenosis; 3-vessel disease = triple coronary stenosis; MR = mitral regurgitation NS = not significant;
